Dinan, M. A., Mi, X., Reed, S. D., Hirsch, B. R., Lyman, G. H., & Curtis, L. H. (2014). Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007. In Journal of Clinical Oncology (Vol. 32, pp. 6508–6508). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.6508

Dinan, Michaela Ann, Xiaojuan Mi, Shelby D. Reed, Bradford Richard Hirsch, Gary H. Lyman, and Lesley H. Curtis. “Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007.” In Journal of Clinical Oncology, 32:6508–6508. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.6508.

Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH. Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 6508–6508.

Dinan, Michaela Ann, et al. “Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 6508–6508. Crossref, doi:10.1200/jco.2014.32.15_suppl.6508.

Dinan MA, Mi X, Reed SD, Hirsch BR, Lyman GH, Curtis LH. Initial utilization of Oncotype DX in the Medicare population between 2005 and 2007. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 6508–6508.